Measuring clinicians' shared decision-making (SDM) performance is a key requirement given the intensity of policy interest in many developed countries -yet it remains one of the most difficult methodological challenges, which is a concern for many stakeholders. In this Viewpoint Article, we investigate the development of existing patient-reported measures (PRMs) of SDM identified in a recent review. We find that patients were involved in the development of only four of the 13 measures. This lack of patient involvement in PRM development is associated with two major threats to content validity, common to all 13 PRMs of SDM: (i) an assumption of patient awareness of 'decision points' and (ii) an assumption that there is only one decision point in each healthcare consultation. We provide detailed examples of these threats and their impact on accurate assessment of SDM processes and outcomes, which may hamper efforts to introduce incentives for SDM implementation. We propose cognitive interviewing as a recommended method of involving patients in the design of PRMs in the field of SDM and provide a practical example of this approach.
Shared decision making -a measurement challenge
The methodological challenge of measuring shared decision making (SDM) is increasingly relevant to health professionals and policymakers. [1] [2] [3] [4] In the USA, the quality of patient-centred care, including SDM, may soon be incentivized with financial remuneration for health professionals, 3, 5 and in the UK, the inclusion of indicators of patient centeredness in the Quality and Outcomes Framework has been mooted as a possible incentive for SDM. 6 Leaders in the field of SDM are engaged in a series of roundtable discussions, facilitated by the Institute of Medicine, tasked with identifying valid and reliable measures of SDM. Without such measures, accurate assessments of clinical performance will be difficult and the impact of incentives on the implementation of SDM impeded.
measures (PREMs), a patient reported of their healthcare experience. SDM measures tend to fall into the later category. Measures of SDM were both unidimensional, 9, 20, 21 and multidimensional, 8, 10, 17 with dimensions including, for example, 'patient satisfaction with decision', 'decisional control' and 'support provided by clinician when making a decision'. The review found good reliability statistics for included measures; however, the validity of many measures remained undetermined and patient involvement in measure development was unclear. Patient involvement in item conception and formulation is recommended in practice [22] [23] [24] [25] and essential to the production of health measurement tools that accurately measure constructs of interest. 26, 27 We supplemented the Scholl et al. review by assessing the formulation of survey items in detail and found a lack of reported patient involvement in the PRM development process. In this commentary, we discuss these findings in relation to standards in item formulation for PRMs and suggest directions for future scale development with a practical example from the recent development of CollaboRATE, a 3-item PRM of SDM process.
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Measuring patient involvement in decisions without patient involvement in measure development
The validity and reliability of PRMs rely on the generation of instructions, items and response options that are understandable to the target audience. [25] [26] [27] 8, 12, 17, 19 explicitly state that patients were involved in the conception or development of the measures (Table 1) . Two papers made a perfunctory effort to describe patient involvement. 8, 19 The development of the combined outcome measure for risk communication and treatment decision-making effectiveness (COMRADE) was based on the results from a series of focus groups, designed to identify important outcomes of consultations for consumers of health care. 17 However, the focus groups were not designed explicitly to inform the creation of a survey, rather the realization that a survey may be needed was a conclusion drawn from the project. Dyadic OPTION, 12,13 a measure of SDM assessing both clinician and patient perspectives, was the only measure with an independent article describing the detail of item development. 12 For Dyadic OPTION, three cycles of cognitive interviews (see Section 'Engaging patients in development using cognitive' for further details the cognitive interviewing method) were conducted with 27 participants from the general public in the UK. Semantic and grammatically difficult terms were identified, construct mismatch was corrected, and patient preferences for item wording were used to create the final set of 12 items. The general lack of patient involvement contrasts with the ethos of patient engagement central to SDM. It is therefore unsurprising that content validity of existing tools has been difficult to demonstrate. 7, 33 It may be that patient involvement in the design of existing PRMs was conducted and not reported, but this possibility also speaks to the lack of emphasis placed on this aspect of measure development. This lack of emphasis is further supported by the limited attention paid to assessing patient involvement in PRM development in current quality appraisal tools for PRMs.
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Resulting threats to validity assumption of patient awareness of 'decision points' and (ii) an assumption that there is only one decision point in each healthcare consultation (Table 1 ). Yet, literature would suggest that these assumptions are often not met, threatening the content validity of resulting measurement.
Assumption of patient awareness of decision points: 'The decision? What decision?' All 13 PRMs of SDM assume that patients are aware that a decision has been made (Table 1) , and all but one 18 include the term 'decision.'
However, several authors 30, 32, 36, 37 have noted instances where, to an independent observer, a seemingly obvious decision has occurred but patients are unaware. For example, in a study of women who had undergone a hysterectomy, some women had difficulty identifying when a discrete decision to have a hysterectomy occurred. 30 Further work by Entwistle 32 in a general practice population found that patients struggled to identify a decision point because they did not know what constituted a decision. Additionally, Davey et al. 31 report that patients consider some treatment so obvious that there is no decision to be made. There are many instances where decisions are made implicitly during consultations and may not be recognized by patients. This is especially the case where procedures have become routinized in health care, such as a 'diagnostic' performed following the identification of a breast lump. 31 Also, where patients see no acceptable alternative, they may implicitly assume that no decision-making opportunity exists; when faced with a decision about paediatric allogeneic blood and marrow transplantation, 81% of parents reported that there was no decision to be made. 37 In such examples, the use of the terms 'decision' or 'option' may not be appropriate because patients believe they are 'agreeing to a plan' rather than encountering a decision-making point. 37 More work is required in defining what actually constitutes a decision. 38 In a recent study, discordance between patients' and clinicians' perceptions of whether a specific decision was made occurred in 30% of consultations. In half of the consultations where discordance was reported, the patient felt a decision was made and the provider did not, with the opposite true in the remaining consultations. Assuming that patients are always aware of decision points introduces measurement bias, limiting the validity of existing PRMs. Patients cannot accurately answer questions about the processes or outcomes of a decision if they are not aware that a decision has taken place, and though in some instances, where it is known in advance of the consultation that the patient will encounter an explicit decision, the risks associated with this assumption are minimal. 9, 20, 21 A solution may be to remove terms such as 'decision' from PRMs and use wordings that are better understood by patients (an example is provided in Section 'Engaging patients in development using cognitive'). [43] [44] [45] SDM relies on skills that can be taught to clinicians and applied to the whole consultation, rather than an approach to care sanctioned for a limited number of acute, one-off decisions. 46 As decisions do not always occur as the result of a discrete one-off process during a single consultation, 47 designing measures that account for prior experiences is a challenge that warrants further detailed exploration.
Engaging patients in development using cognitive interviews
Existing measures have been designed chiefly for research purposes and without patient input. Future surveys need to be tailored for clinical implementation, namely they need to be short and easy to complete without compromising their ability to discriminate between high and low quality of the SDM process. Within the field of SDM measurement, there is a need to develop key concepts in a rigorous way, based on literature reviews, expert opinions and patient perspectives. Interviews and focus groups provide a way to examine the concordance between the intended measurement concept and the way patients from the target population understand concepts. 24, 25 Once clearly defined, initial items can then be generated, with patients, to measure the concepts. The inclusion of patients in the conception of items and the identification of constructs that matter most to them is a pertinent, but often overlooked step. It is important that these initial items are open to refinement, with cognitive interviews identified as the recommended method to inform this process. 26, 27 There are two main approaches to cognitive interviewing, think aloud and verbal probing. Verbal probing is the recommended approach for the assessment of item comprehension. It involves the interviewer using a series of pre-specified questions to 'probe' further into the interviewee's responses. 26 However, cognitive interviews are not without limitations. As a qualitative method, cognitive interviews may generate a sample unrepresentative of the target populations. In addition, the cognitive interview setting is often a different environment from the setting in which the test material, such as surveys, will be administered. Interviewees tend to pay more attention to materials during a cognitive interview than they would in real world administration, leading to unanticipated problems. However, the risk of this can be mitigated if interviewees are not enticed to focus on materials they find boring or confusing.
26 Table 2 provides an illustrative example of the application of cognitive interviewing to assess comprehension and face validity of CollaboRATE, a 3-item measure of SDM processes which attempts to capture both implicit and explicit decision making over an entire consultation. 28 We conducted two stages of cognitive interviews and piloted the refined survey with 30 patients. In an attempt to mitigate potential limitations of the cognitive interview method, we purposefully sampled interviewees to ensure an equivalent distribution of age and gender; however, we were unable to do this for education, and the majority of our sample had a university-level education.
Interviewees found the term 'preference' difficult to comprehend and preferred the phrase 'what matters most'. The term 'health problem' was perceived as negative by interviewees, leading to the use of 'health issue'. Not only were items refined through the cognitive interview process, item generation also occurred. CollaboRATE initially consisted of two items that assessed the core elements of SDM, (i) providing the patient with an explanation of health information and (ii) patient preference elicitation. Yet, a key insight from the first rounds of cognitive interviews led to the inclusion of a third item, preference integration, directly derived from a patient interview. This item assesses the extent to which patient preferences are integrated into a decision. The inclusion of patients as part of the study team may have helped identify this issue earlier in the project. We now include patients in all projects originating from the 'preference laboratory', Dartmouth College. We hope this practical example can act as a roadmap, informing an important facet of the development and assessment of PRMs in SDM.
